|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0021344,
umls-concept:C0025260,
umls-concept:C0042210,
umls-concept:C0205263,
umls-concept:C0332307,
umls-concept:C0355642,
umls-concept:C0439662,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C1325725
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
2007-6-5
|
|
pubmed:abstractText |
The duration of protection afforded by vaccines represents a critical test of their utility as public health interventions. Some vaccines induce long-term immunity, while others require booster doses. Vaccines that induce long-term protection are usually characterized by the generation of immune memory. Recent trials of a quadrivalent (types 6, 11, 16, 18) human papillomavirus (HPV) vaccine have demonstrated high efficacy through 5 years of follow-up. We evaluated the extent to which the vaccine is able to generate HPV type-specific immune memory.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0264-410X
|
|
pubmed:author |
pubmed-author:Andersson-EllstromAgnetaA,
pubmed-author:AndradeRosires PRP,
pubmed-author:BarrEliavE,
pubmed-author:CostaRonaldo L RRL,
pubmed-author:ElfgrenKristinaK,
pubmed-author:EsserMark TMT,
pubmed-author:GiacolettiKatherineK,
pubmed-author:HøyeJohnJ,
pubmed-author:IversenOle-ErikOE,
pubmed-author:LehtinenMattiM,
pubmed-author:LupinacciLisaL,
pubmed-author:MalmChristianC,
pubmed-author:OlssonSven-EricSE,
pubmed-author:PaavonenJormaJ,
pubmed-author:PettaCarlos ACA,
pubmed-author:Riis-JohannessenGreteG,
pubmed-author:SaahAlfred JAJ,
pubmed-author:SteinwallMargaretaM,
pubmed-author:TammsGretchen MGM,
pubmed-author:VillaLuisa LLL,
pubmed-author:VuocoloScott CSC,
pubmed-author:von KroghGeoG
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4931-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17499406-Adolescent,
pubmed-meshheading:17499406-Adult,
pubmed-meshheading:17499406-Antibodies, Viral,
pubmed-meshheading:17499406-Dose-Response Relationship, Drug,
pubmed-meshheading:17499406-Double-Blind Method,
pubmed-meshheading:17499406-Follow-Up Studies,
pubmed-meshheading:17499406-Human papillomavirus 11,
pubmed-meshheading:17499406-Human papillomavirus 16,
pubmed-meshheading:17499406-Human papillomavirus 18,
pubmed-meshheading:17499406-Humans,
pubmed-meshheading:17499406-Immunization Schedule,
pubmed-meshheading:17499406-Immunologic Memory,
pubmed-meshheading:17499406-Papillomavirus Infections,
pubmed-meshheading:17499406-Papillomavirus Vaccines
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
|
|
pubmed:affiliation |
Karolinska Institute at Danderyds Hospital, SE-182 88 Danderyd, Sweden. sven-eric.olsson@ds.se
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
